YCW16· OtherPerlara
Perlara: building the YC for rare disease parents
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Adjacent
Overlapping tags, a different niche.
Also from W16
Batchmates in Winter 2016.
AlgorizW16Algoriz is an AI based algorithmic trading platform that enables you…Inactive
CaperW16Plug-and-play cashier-less retail powered by computer vision and AIAcquired
CastleW16Block bots & bad behaviorActive
ChatfuelW16Platform to easily create chatbots to engage with audiences on…Active
DailyW16Conversational Voice and Multimodal AI built with Open SourceActive
DeepgramW16Building foundational AI for speech transcription and understanding.Active
About Perlara
Perlara 1.0 (Feb 2014 - Feb 2019) launched early R&D joint ventures called PerlQuests with highly motivated rare disease families, companies or impact investors. We screened gene-edited patient avatars for repurposable drugs in order to build a predictive R&D engine called ArkBase. We planned to monetize programs based on ArkBase predictions by selectively spinning out asset-centric clinical development NewCos. Perlara 1.5 (March 2019 - April 2020) was the transition to a one-person virtual clinical development company and when the epalrestat and aripiprazole repurposing trials were launched at Mayo Clinic for the treatment of PMM2-CDG and NGLY1-CDDG, respectively. Perlara 2.0 (May 2020 --> The first decentralized and distributed biotech
San Francisco, CA, USA; Oakland, CA, USA; Remote
Perlara: questions
Which YC batch was Perlara in?
Perlara was in Y Combinator's Winter 2016 batch (W16).
Is Perlara still active?
Y Combinator lists Perlara as active.
Where is Perlara based?
Perlara lists San Francisco, CA, USA; Oakland, CA, USA; Remote as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.